Unknown

Dataset Information

0

Europium (III) chelate microparticle-based lateral flow immunoassay strips for rapid and quantitative detection of antibody to hepatitis B core antigen.


ABSTRACT: Quantitative hepatitis B core antigen (anti-HBc) measurements could play an important role in evaluating therapeutic outcomes and optimizing the antiviral therapy of chronic hepatitis B infection. In this study, we have developed a simple and rapid fluorescence point-of-care test based on a lateral flow immunoassay (LFIA) method integrated with Eu (III) chelate microparticles to quantitatively determine anti-HBc concentrations in serum. This assay is based on a direct competitive immunoassay performed on lateral flow test strips with an assay time of 15?min. The Eu (III) chelate microparticle-based LFIA assay could quantitatively detect anti-HBc levels with a limit of detection of 0.31 IU mL-1, and exhibited a wide linear range (0.63-640 IU mL-1). The intra- and inter-assay coefficients of variation for anti-HBc were both less than 10% and a satisfactory dilution test and accuracy were demonstrated. There were no statistically significant differences in sensitivity or specificity in serum samples between the Eu (III) chelate microparticle-based LFIA strips and the Abbott Architect kit. A simple, rapid and effective quantitative detection of anti-HBc was possible using the Eu (III) chelate microparticle-based LFIA strips. The strips will provide diagnostic value for clinical application.

SUBMITTER: Liang RL 

PROVIDER: S-EPMC5658374 | biostudies-literature | 2017 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Europium (III) chelate microparticle-based lateral flow immunoassay strips for rapid and quantitative detection of antibody to hepatitis B core antigen.

Liang Rong-Liang RL   Deng Qiao-Ting QT   Chen Zhen-Hua ZH   Xu Xu-Ping XP   Zhou Jian-Wei JW   Liang Jun-Yu JY   Dong Zhi-Ning ZN   Liu Tian-Cai TC   Wu Ying-Song YS  

Scientific reports 20171026 1


Quantitative hepatitis B core antigen (anti-HBc) measurements could play an important role in evaluating therapeutic outcomes and optimizing the antiviral therapy of chronic hepatitis B infection. In this study, we have developed a simple and rapid fluorescence point-of-care test based on a lateral flow immunoassay (LFIA) method integrated with Eu (III) chelate microparticles to quantitatively determine anti-HBc concentrations in serum. This assay is based on a direct competitive immunoassay per  ...[more]

Similar Datasets

| S-EPMC7086788 | biostudies-literature
| S-EPMC8722402 | biostudies-literature
| S-EPMC7127147 | biostudies-literature
| S-EPMC4977790 | biostudies-literature
| S-EPMC8758895 | biostudies-literature
| S-EPMC8746978 | biostudies-literature
| S-EPMC2951490 | biostudies-literature
| S-EPMC8232291 | biostudies-literature
| S-EPMC8646881 | biostudies-literature
| S-EPMC7813740 | biostudies-literature